Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  842 نتائج ل ""Bronchodilator Agents""

فلترة النتائج

Subject : severity of illness index
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.

  • Authors : Prakash A; Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Kaur S

Subjects: Severity of Illness Index* ; COVID-19 Drug Treatment*; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

  • Source: Indian journal of pharmacology [Indian J Pharmacol] 2021 May-Jun; Vol. 53 (3), pp. 236-243.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print Cited Medium: Internet ISSN: 1998-3751

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Measuring disease activity in COPD: is clinically important deterioration the answer?

  • Authors : Singh D; University of Manchester, Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester, UK. .; Criner GJ

Subjects: Disease Progression* ; Severity of Illness Index*; Lung/Lung/Lung/*physiology

  • Source: Respiratory research [Respir Res] 2020 Jun 02; Vol. 21 (1), pp. 134. Date of Electronic Publication: 2020 Jun 02.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.

  • Authors : Martinez FJ; Weill Cornell Medical College, New York-Presbyterian Hospital/Weill Cornell Medical Center, 525 E 68th St, Room M-522, Box 130, New York, NY, 10065, USA. .; Lipworth BJ

Subjects: Severity of Illness Index*; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage ; Formoterol Fumarate/Formoterol Fumarate/Formoterol Fumarate/*administration & dosage

  • Source: Respiratory research [Respir Res] 2020 May 25; Vol. 21 (1), pp. 128. Date of Electronic Publication: 2020 May 25.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD).

  • Authors : Donohue JF; Pulmonary Medicine, UNC School of Medicine, Chapel Hill, NC, USA.; Kerwin E

Subjects: Severity of Illness Index*; Benzamides/Benzamides/Benzamides/*administration & dosage ; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*administration & dosage

  • Source: Respiratory research [Respir Res] 2019 Oct 30; Vol. 20 (1), pp. 241. Date of Electronic Publication: 2019 Oct 30.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.

  • Authors : Chen CZ; Department of Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Ou CY

Subjects: Bronchodilator Agents* ; Forced Expiratory Volume* ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/classification

  • Source: COPD [COPD] 2012 Jun; Vol. 9 (3), pp. 276-80. Date of Electronic Publication: 2012 Feb 23.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101211769 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

COPD Management in the Primary Care Setting.

  • Authors : Skolnik N; Abington Hospital-Jefferson Health, Jenkintown, PA, USA.; Kaplan AG

Subjects: Practice Patterns, Physicians'* ; Severity of Illness Index*; Bronchodilator Agents/Bronchodilator Agents/Bronchodilator Agents/*therapeutic use

  • Source: The Journal of family practice [J Fam Pract] 2018 Oct; Vol. 67 (10 Suppl), pp. S27-S32.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Interpreting Recent Developments in COPD Treatments.

  • Authors : Sethi S; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University at Buffalo, State University of New York, NY, USA.; Dransfield MT

Subjects: Evidence-Based Medicine* ; Severity of Illness Index*; Primary Health Care/Primary Health Care/Primary Health Care/*standards

  • Source: The Journal of family practice [J Fam Pract] 2018 Oct; Vol. 67 (10 Suppl), pp. S33-S39.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Clinical Scores for Dyspnoea Severity in Children: A Prospective Validation Study.

  • Authors : Eggink H; Princess Amalia Children's Clinic, Isala, Zwolle, the Netherlands.; University Medical Center Groningen, Groningen, the Netherlands.

Subjects: Severity of Illness Index*; Asthma/Asthma/Asthma/*drug therapy ; Dyspnea/Dyspnea/Dyspnea/*diagnosis

  • Source: PloS one [PLoS One] 2016 Jul 06; Vol. 11 (7), pp. e0157724. Date of Electronic Publication: 2016 Jul 06 (Print Publication: 2016).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma.

  • Authors : Beeh KM; Insaf GmbH Institut für Atemwegsforschung, Biebricher Allee 34, D-65187, Wiesbaden, Germany. .; LaForce C

Subjects: Severity of Illness Index*; Albuterol, Ipratropium Drug Combination/Albuterol, Ipratropium Drug Combination/Albuterol, Ipratropium Drug Combination/*administration & dosage ; Asthma/Asthma/Asthma/*diagnosis

  • Source: Respiratory research [Respir Res] 2015 Jul 16; Vol. 16, pp. 87. Date of Electronic Publication: 2015 Jul 16.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale.

Subjects: Quality of Life*/Quality of Life*/Quality of Life*/psychology ; Severity of Illness Index*; Fatigue/Fatigue/Fatigue/*diagnosis

  • Source: Health and quality of life outcomes [Health Qual Life Outcomes] 2012 Aug 23; Vol. 10, pp. 100. Date of Electronic Publication: 2012 Aug 23.Publisher: BioMed Central Country of Publication: England NLM ID: 101153626 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7525

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  842 نتائج ل ""Bronchodilator Agents""